Global gene expression profiles of ischemic preconditioning in deceased donor liver transplantation

Liver Transplantation

Volumn 16, Issue 5, 2010, Pages 588-599

  Raza, Ali ^a   Dikdan, George ^b   Desai, Kunj K ^b   Shareef, Asif ^b   Fernandes, Helen ^b   Aris, Virginie ^b   De La Torre, Andrew N ^b   Wilson, Dorian ^b   Fisher, Adrian ^b   Soteropoulos, Patricia ^b   Koneru, Baburao ^b  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID SYNTHASE; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE M3; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; SOMATOMEDIN BINDING PROTEIN 1; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ADULT; APOPTOSIS; ARTICLE; CELL GROWTH; CELL MATURATION; COMPETITIVE INHIBITION; CONTROLLED STUDY; CRYOPRESERVATION; FEMALE; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; HUMAN; IMMUNOBLOTTING; ISCHEMIA; ISCHEMIC PRECONDITIONING; LIPOGENESIS; LIVER BIOPSY; LIVER GRAFT; LIVER TRANSPLANTATION; MALE; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; ORGAN DONOR; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REPERFUSION INJURY; UNINDEXED SEQUENCE;

ADULT; ANTIOXIDANTS; BIOPSY; BLOTTING, WESTERN; CADAVER; CELL DIVISION; ENZYMES; FEMALE; GENE EXPRESSION PROFILING; HUMANS; ISCHEMIC PRECONDITIONING; LIPID METABOLISM; LIVER; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TISSUE DONORS;

EID: 77951716863     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.22049     Document Type: Article

References (59)

1. Glanemann M, Langrehr JM, Stange BJ, Neumann U, Settmacher U, Steinmuller T, et al. Clinical implications of hepatic preservation injury after adult liver transplantation. Am J Transplant 2003;3:1003-1009. (Pubitemid 36917548)
2. Hilmi I, Horton CN, Planinsic RM, Sakai T, Nicolau-Raducu R, Damian D, et al. The impact of postreperfusion syndrome on short-term patient and liver allograft outcome in patients undergoing orthotopic liver transplantation. Liver Transpl 2008;14:504-508. (Pubitemid 351524406)
3. Clavien PA, Harvey PR, Strasberg SM. Preservation and reperfusion injuries in liver allografts. An overview and synthesis of current studies. Transplantation 1992;53:957-978.
4. Axelrod DA, Schnitzler M, Salvalaggio PR, Swindle J, Abecassis MM. The economic impact of the utilization of liver allografts with high donor risk index. Am J Transplant 2007;7:990-997. (Pubitemid 46481202)
5. Busuttil RW, Tanaka K. The utility of marginal donors in liver transplantation. Liver Transpl 2003;9:651-663. (Pubitemid 36874450)
6. Foster R, Zimmerman M, Trotter JF. Expanding donor options: marginal, living, and split donors. Clin Liver Dis 2007;11:417-429. (Pubitemid 46990956)
7. Mokuno Y, Berthiaume F, Tompkins RG, Balis UJ, Yarmush ML. Technique for expanding the donor liver pool: heat shock preconditioning in a rat fatty liver model. Liver Transpl 2004;10:264-272. (Pubitemid 38240126)
8. Compagnon P, Lindell S, Ametani MS, Gilligan B, Wang HB, D'Alessandro AM, et al. Ischemic preconditioning and liver tolerance to warm or cold ischemia: experimental studies in large animals. Transplantation 2005;79:1393-1400. (Pubitemid 40734803)
9. Rahbari NN, Wente MN, Schemmer P, Diener MK, Hoffmann K, Motschall E, et al. Systematic review and metaanalysis of the effect of portal triad clamping on outcome after hepatic resection. Br J Surg 2008;95:424-432.
10. Gurusamy KS, Kumar Y, Sharma D, Davidson BR. Ischaemic preconditioning for liver transplantation. Cochrane Database Syst Rev 2008;(1):CD006315.
11. Beck-Schimmer B, Breitenstein S, Urech S, De Conno E, Wittlinger M, Puhan M, et al. A randomized controlled trial on pharmacological preconditioning in liver surgery using a volatile anesthetic. Ann Surg 2008;248:909-918.
12. Baumann J, Ghosh S, Szakmany T, Jancso G, Ferencz A, Roth E, et al. Short-term effects of N-acetylcysteine and ischemic preconditioning in a canine model of hepatic ischemia-reperfusion injury. Eur Surg Res 2008;41:226-230.
13. Lai IR, Chang KJ, Tsai HW, Chen CF. Pharmacological preconditioning with simvastatin protects liver from ischemia-reperfusion injury by heme oxygenase-1 induction. Transplantation 2008;85:732-738.
14. Niemann CU, Hirose R, Liu T, Behrends M, Brown JL, Kominsky DF, et al. Ischemic preconditioning improves energy state and transplantation survival in obese Zucker rat livers. Anesth Analg 2005;101:1577-1583. (Pubitemid 41720600)
15. Yin DP, Sankary HN, Chong AS, Ma LL, Shen J, Foster P, et al. Protective effect of ischemic preconditioning on liver preservation-reperfusion injury in rats. Transplantation 1998;66:152-157. (Pubitemid 28369992)
16. Arai M, Thurman RG, Lemasters JJ. Ischemic preconditioning of rat livers against cold storage-reperfusion injury: role of nonparenchymal cells and the phenomenon of heterologous preconditioning. Liver Transpl 2001;7:292-299. (Pubitemid 32331531)
17. Serafin A, Rosello-Catafau J, Prats N, Xaus C, Gelpi E, Peralta C. Ischemic preconditioning increases the tolerance of fatty liver to hepatic ischemia-reperfusion injury in the rat. Am J Pathol 2002;161:587-601. (Pubitemid 36142167)
18. Cescon M, Grazi GL, Grassi A, Ravaioli M, Vetrone G, Ercolani G, et al. Effect of ischemic preconditioning in whole liver transplantation from deceased donors. A pilot study. Liver Transpl 2006;12:628-635.
19. Jassem W, Fuggle SV, Cerundolo L, Heaton ND, Rela M. Ischemic preconditioning of cadaver donor livers protects allografts following transplantation. Transplantation 2006;81:169-174.
20. Amador A, Grande L, Marti J, Deulofeu R, Miquel R, Sola A, et al. Ischemic pre-conditioning in deceased donor liver transplantation: a prospective randomized clinical trial. Am J Transplant 2007;7:2180-2189. (Pubitemid 47247061)
21. Azoulay D, Del Gaudio M, Andreani P, Ichai P, Sebag M, Adam R, et al. Effects of 10 minutes of ischemic preconditioning of the cadaveric liver on the graft's preservation and function: the ying and the yang. Ann Surg 2005;242:133-139. (Pubitemid 40917977)
22. Koneru B, Shareef A, Dikdan G, Desai K, Klein KM, Peng B, et al. The ischemic preconditioning paradox in deceased donor liver transplantation- evidence from a prospective randomized single blind clinical trial. Am J Transplant 2007;7:2788-2796. (Pubitemid 350045783)
23. Koneru B, Fisher A, He Y, Klein KM, Skurnick J, Wilson DJ, et al. Ischemic preconditioning in deceased donor liver transplantation: a prospective randomized clinical trial of safety and efficacy. Liver Transpl 2005;11:196-202. (Pubitemid 40268217)
24. Gomez D, Homer-Vanniasinkam S, Graham AM, Prasad KR. Role of ischaemic preconditioning in liver regeneration following major liver resection and transplantation. World J Gastroenterol 2007;13:657-670. (Pubitemid 46252387)
25. Ishida T, Yarimizu K, Gute DC, Korthuis RJ. Mechanisms of ischemic preconditioning. Shock 1997;8:86-94.
26. Amour J, Brzezinska AK, Weihrauch D, Billstrom AR, Zielonka J, Krolikowski JG, et al. Role of heat shock protein 90 and endothelial nitric oxide synthase during early anesthetic and ischemic preconditioning. Anesthesiology 2009;110:317-325.
27. Barrier A, Olaya N, Chiappini F, Roser F, Scatton O, Artus C, et al. Ischemic preconditioning modulates the expression of several genes, leading to the overproduction of IL-1Ra, iNOS, and Bcl-2 in a human model of liver ischemia-reperfusion. FASEB J 2005;19:1617-1626. (Pubitemid 41429519)
28. Feng S, Goodrich NP, Bragg-Gresham JL, Dykstra DM, Punch JD, DebRoy MA, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant 2006;6:783-790. (Pubitemid 43345017)
29. Bolstad BM, Irizarry RA, Astrand M, Speed TP. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003;19:185-193. (Pubitemid 36181903)
30. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003;4:249-264.
31. Saeed AI, Sharov V, White J, Li J, Liang W, Bhagabati N, et al. TM4: a free, open-source system for microarray data management and analysis. Biotechniques 2003;34:374-378. (Pubitemid 36184095)
32. Raychaudhuri S, Stuart JM, Altman RB. Principal components analysis to summarize microarray experiments: application to sporulation time series. Pac Symp Biocomput 2000;5:455-466.
33. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 1998;95:14863-14868. (Pubitemid 29003722)
34. Deryckere F, Gannon F. A one-hour minipreparation technique for extraction of DNA-binding proteins from animal tissues. Biotechniques 1994;16:405. (Pubitemid 24079501)
35. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-685.
36. Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009;4:44-57.
37. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, et al. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 2003;4:P3.
38. Jassem W, Fuggle S, Thompson R, Arno M, Taylor J, Byrne J, et al. Effect of ischemic preconditioning on the genomic response to reperfusion injury in deceased donor liver transplantation. Liver Transpl 2009;15:1750-1765.
39. Koti RS, Seifalian AM, Davidson BR. Protection of the liver by ischemic preconditioning: a review of mechanisms and clinical applications. Dig Surg 2003;20:383-396. (Pubitemid 37116937)
40. Banga NR, Homer-Vanniasinkam S, Graham A, Al-Mukhtar A, White SA, Prasad KR. Ischaemic preconditioning in transplantation and major resection of the liver. Br J Surg 2005;92:528-538. (Pubitemid 40685646)
41. Yuan GJ, Ma JC, Gong ZJ, Sun XM, Zheng SH, Li X. Modulation of liver oxidant-antioxidant system by ischemic preconditioning during ischemia/reperfusion injury in rats. World J Gastroenterol 2005;11:1825-1828. (Pubitemid 40520778)
42. Lai IR, Ma MC, Chen CF, Chang KJ. The protective role of heme oxygenase-1 on the liver after hypoxic preconditioning in rats. Transplantation 2004;77:1004-1008. (Pubitemid 38508913)
43. Covolo L, Gelatti U, Talamini R, Garte S, Trevisi P, Franceschi S, et al. Alcohol dehydrogenase 3, glutathione S-transferase M1 and T1 polymorphisms, alcohol consumption and hepatocellular carcinoma (Italy). Cancer Causes Control 2005;16:831-838. (Pubitemid 41160046)
44. Jefferies H, Coster J, Khalil A, Bot J, McCauley RD, Hall JC. Glutathione. ANZ J Surg 2003;73:517-522.
45. Borentain P, Gerolami V, Ananian P, Garcia S, Noundou A, Botta-Fridlund D, et al. DNA-repair and carcinogen-metabolising enzymes genetic polymorphisms as an independent risk factor for hepatocellular carcinoma in Caucasian liver-transplanted patients. Eur J Cancer 2007;43:2479-2486. (Pubitemid 350086929)
46. Conti A, Scala S, D'Agostino P, Alimenti E, Morelli D, Andria B, et al. Wide gene expression profiling of ischemia- reperfusion injury in human liver transplantation. Liver Transpl 2007;13:99-113. (Pubitemid 46099979)
47. Huda R, Chung DH, Mathru M. Ischemic preconditioning at a distance: altered gene expression in mouse heart and other organs following brief occlusion of the mesenteric artery. Heart Lung Circ 2005;14:36-43. (Pubitemid 40883119)
48. Sergeev P, da Silva R, Lucchinetti E, Zaugg K, Pasch T, Schaub MC, et al. Trigger-dependent gene expression profiles in cardiac preconditioning: evidence for distinct genetic programs in ischemic and anesthetic preconditioning. Anesthesiology 2004;100:474-488. (Pubitemid 38268863)
49. Stenzel-Poore MP, Stevens SL, Xiong Z, Lessov NS, Harrington CA, Mori M, et al. Effect of ischaemic preconditioning on genomic response to cerebral ischaemia: similarity to neuroprotective strategies in hibernation and hypoxia-tolerant states. Lancet 2003;362:1028-1037. (Pubitemid 37186880)
50. St Peter SD, Imber CJ, Jones DC, Fuggle SV, Watson CJ, Friend PJ, et al. Genetic determinants of delayed graft function after kidney transplantation. Transplantation 2002;74:809-813.
51. Platz KP, Mueller AR, Haller GW, Muller C, Wenig M, Neuhaus R, et al. Determination of alpha- and Pi-glutathione-S-transferase will improve monitoring after liver transplantation. Transplant Proc 1997;29:2827-2829. (Pubitemid 27481816)
52. Platz KP, Mueller AR, Muller C, Wenig M, Schumacher G, Steinmuller T, et al. Indications for determination of alpha-glutathione-s-transferase after liver transplantation. Transplant Proc 1999;31:462-464. (Pubitemid 29127530)
53. Gimeno RE, Cao J. Thematic review series: glycerolipids. Mammalian glycerol-3-phosphate acyltransferases: new genes for an old activity. J Lipid Res 2008;49:2079-2088.
54. Hammond LE, Albright CD, He L, Rusyn I, Watkins SM, Doughman SD, et al. Increased oxidative stress is associated with balanced increases in hepatocyte apoptosis and proliferation in glycerol-3-phosphate acyltransferase-1 deficient mice. Exp Mol Pathol 2007;82:210-219. (Pubitemid 46505131)
55. Chavin KD, Fiorini RN, Shafizadeh S, Cheng G, Wan C, Evans Z, et al. Fatty acid synthase blockade protects steatotic livers from warm ischemia reperfusion injury and transplantation. Am J Transplant 2004;4:1440-1447. (Pubitemid 39159058)
56. Khai NC, Takahashi T, Ushikoshi H, Nagano S, Yuge K, Esaki M, et al. In vivo hepatic HB-EGF gene transduction inhibits Fas-induced liver injury and induces liver regeneration in mice: a comparative study to HGF. J Hepatol 2006;44:1046-1054.
57. Leu JI, George DL. Hepatic IGFBP1 is a prosurvival factor that binds to BAK, protects the liver from apoptosis, and antagonizes the proapoptotic actions of p53 at mitochondria. Genes Dev 2007;21:3095-3109.
58. Kimberley FC, Screaton GR. Following a TRAIL: update on a ligand and its five receptors. Cell Res 2004;14:359-372. (Pubitemid 43231798)
59. Wei W, Liu Y, Zheng D. Current understanding on the immunological functions of tumor necrosis factor-related apoptosis-inducing ligand. Cell Mol Immunol 2005;2:265-269.